News Release

Researchers of Tokyo Metropolitan Institute of Medical Science and National Institute of Mental Health proposed that the pathological mechanism of intellectual disability caused by RP58/ZBTB18 haploinsufficiency may be a disorder of excitatory synapses

Peer-Reviewed Publication

Tokyo Metropolitan Institute of Medical Science

Establishments of a mouse model of intellectual disability

image: RP58/ZBTB18 is a transcriptional repressor protein, and the gene is located on chromosome 1. Missense or truncating variants, or deletion of RP58/ZBTB18 reduces the function of RP58, resulting in the induction of intellectual disability. To elucidate this pathology, we generated and analyzed Rp58 heterozygous deletion mice and found behavioral abnormalities resembling patients with intellectual disability. Specifically, in addition to reduced working memory, we found reduced reversal learning ability in the water maze test, suggesting reduced flexibility in cognitive memory capacity. These results can be considered to correspond to a decline in intellectual function and adaptive capacity observed in patients with intellectual disability. There are two possible reasons why these behavioral phenotypes were observed in RP58 heterozygous mice. 1. The mouse model showed abnormalities in glutamatergic signaling; when we examined long-term potentiation involving NMDA receptors, we found that there was no difference in long-term potentiation with a single frequent stimulus, but that long-term potentiation saturated at a lower rate with repeated frequent stimulation. This change in synaptic plasticity properties indicates a smaller capacity for plasticity in memory learning, suggesting that it is the basis for reduced plasticity. 2. Analysis of dendritic spine morphology revealed abnormalities in mature-type spine morphology, with smaller spine head widths and shorter spine lengths in Rp58 heterozygous mice, suggesting maturation defects in mature-type spines. view more 

Credit: TMIMS

In this study, we generated and analyzed Rp58 heterozygous mice as a model of RP58/ZBTB18 haploinsufficiency, and we clarified the following four points.

(1) Histological analysis of the brain of this model mouse showed no significant abnormality in the formation of the cortical layers, but it did show dysplasia of the corpus callosum. This is an abnormality that has also been reported in patients with RP58/ZBTB18 haploinsufficiency.

(2) This mouse model showed impairment of motor learning, working memory, and cognitive memory flexibility. These phenotypes are similar to the symptoms of intellectual disability.

(3) Decreased expression of glutamate receptors was found in the cerebral cortex of the above mice. In addition, the response of NMDA receptors in hippocampal CA1 neurons was abnormal, and the saturation level of synaptic long-term potentiation was reduced after repeated frequent stimulation. These indicate abnormalities in glutamate receptor synaptic responses, which play an important role in memory and learning functions.

(4) Furthermore, morphological analysis of the hippocampal CA1 pyramidal cell spine revealed maturation defects in mature-type spines..

These results suggest that excitatory synaptic defects exist in the background of RP58/ZBTB18 haploinsufficiency, and they are expected to be useful in the development of prevention and treatment methods for intellectual disabilities caused by RP58/ZBTB18 haploinsufficiency.

Social Significance and Future Prospects

It has been demonstrated that insufficient expression of Rp58 causes cognitive decline, and it has been suggested that one of the causes of this cognitive decline is dysfunction of excitatory synapses of excitatory neurons. This is expected to provide clues for the development of methods to prevent and treat cognitive dysfunction in patients with RP58/ZBTB18 haploinsufficiency. However, the mechanism by which reduced Rp58 expression causes synaptic dysfunction is unknown. It is hoped that the identification of the target gene of RP58 will elucidate the mechanism, and this mouse model will be useful in this regard.

The research results were published online in the American scientific journal Molecular Psychiatry on Wednesday, February 1, 2023 at 10:00 a.m. (Japan Standard Time).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.